CIBC Private Wealth Group
PBYI icon

CIBC Private Wealth Group’s Puma Biotechnology PBYI Stock Holding History

CIBC Private Wealth Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$4.61K Hold
775
– – ﹤0.01% 2645
2025
Q3 		$4.12K Hold
775
– – ﹤0.01% 2608
2025
Q2 		$2.66K Hold
775
– – ﹤0.01% 2578
2025
Q1 		$2.24K Hold
775
– – ﹤0.01% 2654
2024
Q4 		$2.75K Hold
775
– – ﹤0.01% 2635
2024
Q3 		$1.98K Hold
775
– – ﹤0.01% 2803
2024
Q2 		$2.31K Hold
775
– – ﹤0.01% 2733
2024
Q1 		$4.09K Buy
+775
New +$4.17K ﹤0.01% 2562
2018
Q3 		– Sell
-725
Closed -$43K – 1487
2018
Q2 		$43K Buy
725
+590
+437% +$34.2K ﹤0.01% 1205
2018
Q1 		$9K Sell
135
-328
-71% -$24.6K ﹤0.01% 1558
2017
Q4 		$46K Buy
+463
New +$51.8K ﹤0.01% 1209

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC Private Wealth Group's PBYI Position: Q4 2025 in Review

CIBC Private Wealth Group held its Puma Biotechnology (PBYI) position steady in Q4 2025 at 775 shares worth $4.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2645.

CIBC Private Wealth Group first reported a position in PBYI in Q4 2017 and has held it in 11 quarters since. The position peaked at $46K in Q4 2017. 151 funds tracked by Wall St. Rank hold PBYI as of Q4 2025.

  • CIBC Private Wealth Group held 775 shares of Puma Biotechnology worth $4.61K as of Q4 2025.
  • CIBC Private Wealth Group left its Puma Biotechnology share count unchanged in Q4 2025.
  • Puma Biotechnology made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2645 holding.
  • CIBC Private Wealth Group first reported a position in Puma Biotechnology in Q4 2017 and has held it in 11 quarters since.
  • CIBC Private Wealth Group's Puma Biotechnology position peaked at $46K in Q4 2017.
  • 151 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.